Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer

Author contributions Anthony V Nguyen coordinated patient enrollment, specimen acquisition, and performed microarray assays. Micaela Martinez performed quantitative real-time PCR analyses. Michael J Stamos performed patient identification and specimen acquisition. Mary P Moyer provided NCM460 cell line. Kestutis Planutis and Christopher Hope assisted with all laboratory assays. Randall F Holcombe was responsible for the overall study design and supervision, including clinical and basic laboratory components. Disclosure The authors declare that they have no competing interests.